Study of JMKX003948 Ophthalmic Suspension in Healthy Participants

NCT06832657 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Age-Related Macular Degeneration (AMD)
Diabetic Macular Edema (DME)

Interventions

DRUG: JMKX003948 Ophthalmic Suspension
DRUG: Placebo

Sponsor

Jemincare